Skip to main content
See all news

Scheller News

PneumoniaCheck, a device created at Georgia Tech, is a solution to the problem of diagnosing pneumonia.
PneumoniaCheck, a device created at Georgia Tech, is a solution to the problem of diagnosing pneumonia.
David Ku, Georgia Tech Regents’ Professor of Mechanical Engineering, L.P. Huang Chair Professor for Engineering Entrepreneurship in the College of Management, and Professor of Surgery at Emory University, with former graduate students, Tamera Scholz, (center) MS in Mechanical Engineering 2010, and Taylor Bronikowski (right) MBA 2010.
David Ku, Georgia Tech Regents’ Professor of Mechanical Engineering, L.P. Huang Chair Professor for Engineering Entrepreneurship in the College of Management, and Professor of Surgery at Emory University, with former graduate students, Tamera Scholz, (center) MS in Mechanical Engineering 2010, and Taylor Bronikowski (right) MBA 2010.

MBA Students Develop Business Plan for Better Way to Diagnose Pneumonia

Researchers from the Georgia Institute of Technology have created a new sampling device that could prevent thousands of people worldwide from dying of pneumonia each year. Once the device, called PneumoniaCheck was developed, Taylor Bronikowski (MBA 2010) and other classmates from the College of Management started developing a business plan for it to eventually grow globally.

The device is a solution to the problem of diagnosing pneumonia, which is a major initiative of the U.S. Centers for Disease Control and Prevention (CDC). Pneumonia, an inflammation of the lungs, kills about 2.4 million people each year. The problem is particularly devastating in Africa, Southeast Asia and the Eastern Mediterranean, where a child dies of pneumonia every 15 seconds.

Developed by mechanical engineering students, graduate business students and faculty at Georgia Tech, PneumoniaCheck will be commercially launched this month to healthcare professionals through the startup company, MD Innovate Inc.

"Georgia Tech created a simple and new device to detect the lung pathogens causing pneumonia, " said David Ku, Georgia Tech Regents' Professor of Mechanical Engineering, Lawrence P. Huang Chair Professor for Engineering Entrepreneurship in the College of Management, and Professor of Surgery at Emory University. "It has the potential to save more lives than any other medical device."

Last year, Ku was asked by the head of virology at the CDC to develop a quick and economical way to diagnose pneumonia, particularly in developing nations where it is a leading cause of death among children. u challenged a group of mechanical engineering and bioengineering graduate students to develop an accurate device for diagnosing pneumonia. Current sampling methods using the mouth and nose are only 40 percent effective. The samples are typically contaminated by bacteria in the mouth, which leads to misdiagnosis and an incorrect prescription of antibiotics.

In developing nations, many children with respiratory infections fail to receive adequate care, and the overuse of antibiotics has led to an increase in drug-resistant bacteria. An accurate, easy-to-use and widely available new diagnostic test could improve identification of bacterial respiratory infection in children, reducing the inappropriate use of antibiotics and the long-term negative impacts of drug resistance, according to a recent article in Nature titled "Reducing the global burden of acute lower respiratory infections in children: The contributions of new diagnostics."

As a Tech graduate student, Tamera Scholz and her peers developed the solution – PneumoniaCheck.
The device contains a plastic tube with a mouthpiece. A patient coughs into the device to fill up a balloon-like upper airway reservoir before the lung aerosols go into a filter.  Using fluid mechanics, PneumoniaCheck separates the upper airway particles of the mouth from the lower airway particles coming from the lungs.

"It's interesting because it's so simple," said Scholz (MS 2010, Mechanical Engineering), who is now an engineer for Newell Rubbermaid. "It's not a fancy contraption. It's a device that patients cough into and through fluid mechanics it separates upper and lower airway aerosols. Through each iteration, it got simpler.  … I like that I will be able to see it make a difference in my lifetime."

Bronikowski and other MBA students who developed the business plan for PneumoniaCheck used the device as a as a test case to develop a Triple Bottom Line company in India that could result in financial profits, environmental sustainability and social benefits, such as jobs and healthcare. 

"Our goal is to provide better medicine at a cost savings to patients and hospitals," said Bronikowski, MBA 2010. "We wanted a worldwide solution, so patients in developing nations can afford it."

Bronikowksi, Ku and Sarah Ku formed the startup company, MD Innovate Inc., in 2010 to manufacture the device in large quantities and organize distribution and commercialization. The device is now being used in pneumonia studies at Grady Memorial Hospital in downtown Atlanta and the Atlanta Veterans Administration Medical Center, Ku said.
The FDA has cleared PneumoniaCheck for sale in the U.S. The device is licensed but its patent is pending.  The company will start selling PneumoniaCheck in the U.S. in January and it could hit other countries in two years, Ku said.

It's a great feeling, working on something that has the potential to save thousands of lives," Bronikowski said.
On the horizon, Ku and future Georgia Tech graduate students will be developing a simple and effective method for diagnosing pneumonia in regions without healthcare facilities or basic infrastructure.

Media Relations Contact: Liz Klipp, Institute Communications & Marketing, 404-894-6016

CONTACTS

Profile image for Susan Ambrosetti
Susan Ambrosetti
Director of Marketing & Communications